Commentary
Even before the COVID-19 pandemic gave rise to social distancing and shelter-in-place orders, many older people preferred to receive their healthcare at home.1 Such services are highly relevant for people with chronic obstructive pulmonary disease, in whom disabling symptoms and travel burden are known barriers to accessing healthcare.2 Home-based models are increasingly attractive as an alternative to inpatient admissions, which in chronic obstructive pulmonary disease are the primary contributors to healthcare costs.3
Duiverman et al tested whether initiation of high-intensity non-invasive ventilation at home, including remote adjustment of ventilator settings, was non-inferior to in-hospital initiation for patients with chronic obstructive pulmonary disease and chronic hypercapnic respiratory failure. The between-group difference for the primary outcome (change in daytime partial pressure of carbon dioxide in arterial blood at 6 months) was not clinically significant, with a 95% confidence interval that excluded the non-inferiority margin of 3 mmHg. Improvements in health-related quality of life and symptoms were similar across groups. The cost reduction was considerable (56% lower at home); however, the applicability of this finding will vary across health systems. Hospital initiation of high-intensity non-invasive ventilation required a median of 7.5 inpatient days, which was a major driver of the cost difference. This may not reflect practice in other settings with shorter length of stay, or outpatient-based non-invasive ventilation initiation.4
This study provides confidence that home initiation of non-invasive ventilation is clinically efficacious in severe chronic obstructive pulmonary disease. Home non-invasive ventilation initiation required at least two home visits from a specialist nurse, plus additional visits when technical problems were encountered. Eligible patients were those with sufficient social support to manage home initiation of non-invasive ventilation, which could exclude an important minority of patients who live alone or have no caregiver.5
Acknowledgments
Provenance: Invited. Not peer reviewed.
References
- 1.Dixon S., et al. Health Expect. 2015;18:1204–1214. doi: 10.1111/hex.12096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Cox N.S., et al. J Physiother. 2017;63:84–93. doi: 10.1016/j.jphys.2017.02.002. [DOI] [PubMed] [Google Scholar]
- 3.Khakban A., et al. Chest. 2015;148:640–646. doi: 10.1378/chest.15-0721. [DOI] [PubMed] [Google Scholar]
- 4.Sheers N., et al. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:180–184. doi: 10.3109/21678421.2014.881376. [DOI] [PubMed] [Google Scholar]
- 5.Chen Z., et al. Ann Am Thorac Soc. 2017;14:1419–1427. doi: 10.1513/AnnalsATS.201701-026OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
